Compugen to Present Experimental Data for its Novel Splice Variant of c-Met Receptor.

Extract


Compugen to Present Experimental Data for its Novel Splice Variant of c-Met Receptor.

Data to be presented at GTCBio's Cancer Drugs Research & Development Conference

TEL AVIV, Israel -- Compugen Ltd. (Nasdaq:CGEN) announced today tha...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company